Glow 70mg -Research Peptide

Glow 70 mg — Research Peptide Blend (Technical Information)

1. Product Overview

Glow 70 mg is a synergistic research peptide blend combining three well‑characterized peptides in a single vial, designed to support advanced scientific research into cellular repair, tissue regeneration, and extracellular matrix biology. Each component in the blend has a distinct molecular profile and research pedigree, allowing laboratories to investigate multi‑pathway peptide interactions in regenerative, inflammation‑modulation, and structural biology models.

• Product Name: Glow 70 mg

• Format: Lyophilized peptide powder

• Total Peptide Content: 70 mg per vial (combined)

• Blend Composition: GHK‑Cu (50 mg), BPC‑157 (10 mg), TB‑500 (10 mg)

• Intended Use: For in vitro and controlled laboratory research only (RUO). Not for human or veterinary use.

---

2. Physical & Chemical Specifications

---

3. Composition & Peptide Characteristics

GHK‑Cu (Copper Peptide) — ~50 mg

• A naturally occurring glycyl‑L‑histidyl‑L‑lysine–copper complex used in research for its capacity to modulate gene expression, promote collagen synthesis, and explore oxidative‑stress pathways.

BPC‑157 (Body Protection Compound‑157) — ~10 mg

• A stable synthetic peptide derived from a gastric protein sequence; extensively applied in in vitro studies relating to tendon/ligament repair, angiogenesis, and soft‑tissue integrity.

TB‑500 (Thymosin β‑4 Fragment) — ~10 mg

• A peptide fragment from thymosin β‑4 studied for cell migration, angiogenic processes, and regenerative signaling in tissue cultures.

---

4. Mechanisms & Research Context

Although not approved as therapeutics, each component in the Glow blend contributes distinct biological activities that are valuable in scientific research:

• GHK‑Cu: Studied for its effects on extracellular matrix regulation, collagen/elastin synthesis pathways, and antioxidant responses.

• BPC‑157: Investigated in tissue modeling for fibroblast proliferation, nitric‑oxide signaling, and microvascular repair.

• TB‑500: Explored in research involving cytoskeletal remodeling, angiogenic signals, and progenitor cell recruitment in healing models.

Synergistic Research Value: By formulating these peptides together, Glow enables studies of peptide–peptide interactions, combined signaling pathway effects, and multi‑axis regenerative responses within controlled laboratory environments.

---

5. Reconstitution & Handling (Research Protocols)

Typical Reconstitution Approach (Laboratory):

1. Aseptically add sterile water or bacteriostatic water to the vial to achieve a defined concentration suitable for specific experimental assays.

2. Gently swirl to dissolve without vigorous agitation to preserve peptide integrity.

3. Label with reconstitution details and concentration.

4. Use reconstituted solution promptly; maintain at 2–8 °C for short‑term storage. Freeze aliquots for long‑term studies if needed.

Handling Guidelines:

• Use appropriate PPE and aseptic technique.

• Avoid repeated freeze–thaw cycles.

• Dispose of unused materials per institutional biosafety protocols.

---

6. Research Applications & Use Cases

Glow 70 mg is applicable in a variety of research fields, including:

• Dermatological and cosmetic biology studies (e.g., collagen and extracellular matrix regulation)

• Tissue regeneration and wound‑healing models

• Inflammation modulation and cell‑signaling investigations

• Synergistic peptide interaction research across musculoskeletal, epithelial, and connective tissue systems

---

7. Safety & Regulatory Information

• For research use only (RUO).

• Not intended for human or veterinary consumption or therapeutic, cosmetic, or diagnostic applications.

• Supplied as a sterile lyophilized research reagent; users must comply with laboratory safety and handling protocols.